2009
DOI: 10.1007/s00134-009-1558-5
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive pressure-support ventilation in immunocompromised children with ARDS: a feasibility study

Abstract: NIV administration is feasible and well tolerated in immunocompromised children with ARDS. A short NIV trial can be used to verify the usefulness of the technique. A randomized controlled trial is needed to confirm the efficacy of NIV in immunocompromised children requiring ventilatory support for ARDS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
67
0
10

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 89 publications
(82 citation statements)
references
References 19 publications
5
67
0
10
Order By: Relevance
“…The helmet is supposed to have several advantages over nasal or whole-face masks: it allows free movement of the infant's head as well as a good interaction with the environment while maintaining a good seal without compression. [19][20][21][22][23] In preterm infants with mild respiratory distress, CPAP by helmet resulted in better tolerance and less oxygen desaturation than use of nasal prongs. 17 In preschool children with ARF of mixed etiologies, CPAP by helmet was safe and well tolerated and resulted in an early increase in oxygenation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The helmet is supposed to have several advantages over nasal or whole-face masks: it allows free movement of the infant's head as well as a good interaction with the environment while maintaining a good seal without compression. [19][20][21][22][23] In preterm infants with mild respiratory distress, CPAP by helmet resulted in better tolerance and less oxygen desaturation than use of nasal prongs. 17 In preschool children with ARF of mixed etiologies, CPAP by helmet was safe and well tolerated and resulted in an early increase in oxygenation.…”
Section: Discussionmentioning
confidence: 99%
“…[12][13][14][15][16] A pediatric helmet has been used to deliver CPAP in neonates, infants, and preschool children with ARF. [17][18][19][20][21][22][23] In this population, CPAP by helmet was better tolerated than a facial mask, with no major complications and less need for sedation. [21][22][23] The aim of this prospective multicenter randomized controlled trial (RCT) was to compare the failure rates of helmet and facial mask CPAP in infants admitted to a PICU for RSVrelated ARF.…”
Section: Respiratory Syncytial Virus (Rsv)mentioning
confidence: 99%
“…The study results encourage the use of NIV as the first treatment in oncologic children with respiratory insufficiency, and without hemodynamic instability (19) . Piastra et al (22) developed a prospective cohort study with 23 immunocompromised patients with ARDS admitted to the ICU of a university hospital and treated with NIV. There was no difference in the scores of severity between the NIV responders and non-responders.…”
Section: Stregth Of Recommendationmentioning
confidence: 99%
“…El casco o helmet viene empleándose de forma creciente y exitosa en los últimos años en pacientes adultos 8,9 , si bien es una de las menos conocidas, con escasas referencias en la literatura sobre pacientes pediátricos. En los estudios realizados hasta la fecha en lactantes y niños no se han descrito efectos secundarios derivados del uso de CPAP a través de un sistema helmet 10,11 , a excepción de dolor axilar en 2 pacientes inmunodeprimidos con síndrome de distrés respiratorio agudo 12 . Un estudio que compara el helmet con la mascarilla facial en pacientes pediátricos con insuficiencia respiratoria aguda refiere mejor tolerancia y menor número de lesiones por presión y de fugas aéreas empleando el helmet 13 .…”
unclassified